 | • レポートコード：MRC2102QY4046 • 出版社/出版日： / 2021年1月 • レポート形態：英文、PDF、147ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品、医療 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,200,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYリサーチ社の本調査レポートでは、世界の診断用放射性医薬品市場について種類別（テクネチウム99、フッ素18、その他）、用途別（腫瘍学、心臓病学、その他）、地域別（米国、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・診断用放射性医薬品市場の概要 ・世界の主要地域別診断用放射性医薬品市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の診断用放射性医薬品市場規模2015-2026：種類別（テクネチウム99、フッ素18、その他） ・世界の診断用放射性医薬品市場規模2015-2026：用途別（腫瘍学、心臓病学、その他） ・診断用放射性医薬品の米国市場規模2015-2020 ・診断用放射性医薬品のヨーロッパ市場規模2015-2020 ・診断用放射性医薬品の中国市場規模2015-2020 ・診断用放射性医薬品の日本市場規模2015-2020 ・診断用放射性医薬品の東南アジア市場規模2015-2020 ・診断用放射性医薬品のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・診断用放射性医薬品の製造コスト分析 ・販売チャネル、流通業者、顧客 ・診断用放射性医薬品の市場動向・機会・課題 ・調査の結論 |
Radiopharmaceuticals refer to a class of special medicines containing radionuclides for medical diagnosis and treatment. Compounds or biological preparations containing radionuclide labels used for medical diagnosis or treatment in the body. Diagnostic radiopharmaceuticals are radioisotopes that bind to biomolecules that can locate specific organs, tissues or cells in the body. These radiopharmaceuticals can be used to diagnose diseases.
North America is the world’s major consumer region, with sales accounting for 41.59% of the global total in 2019. Europe is also a major consumer region, accounting for 24.5% of the global market. China is also a very important consumer region due to the large number of cancers. At present, products represented by Cardinal Health, GE Healthcare, Curium Pharma, Jubilant Pharma, Bracco Imaging, etc. occupy a major position in the global market.
Market Analysis and Insights: Global Diagnostic Radiopharmaceuticals Market
The global Diagnostic Radiopharmaceuticals market size is projected to reach US$ 6121.6 million by 2026, from US$ 4102 million in 2020, at a CAGR of 6.9% during 2021-2026.
Global Diagnostic Radiopharmaceuticals Scope and Market Size
The global Diagnostic Radiopharmaceuticals market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Diagnostic Radiopharmaceuticals market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.
Segment by Type, the Diagnostic Radiopharmaceuticals market is segmented into
Technetium 99
Fluorine 18
Other
Diagnostic radiopharmaceuticals are mainly divided into technetium 99, fluorine 18 and others. Among them, technetium 99 accounted for the main part, accounting for about 47.56% of the total market in 2019.
Segment by Application, the Diagnostic Radiopharmaceuticals market is segmented into
Oncology
Cardiology
Other
Diagnostic radiopharmaceutical applications are mainly for oncology, cardiology and others. Among them, oncology accounts for the main part, accounting for about 45.8% of the total market in 2019.
The Diagnostic Radiopharmaceuticals market is analysed and market size information is provided by regions (countries). Segment by Application, the Diagnostic Radiopharmaceuticals market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Diagnostic Radiopharmaceuticals Market Share Analysis
Diagnostic Radiopharmaceuticals market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Diagnostic Radiopharmaceuticals business, the date to enter into the Diagnostic Radiopharmaceuticals market, Diagnostic Radiopharmaceuticals product introduction, recent developments, etc.
The major vendors covered:
Cardinal Health
GE Healthcare
Curium Pharma
Jubilant Pharma
Bracco Imaging
Advanced Accelerator Applications
SIEMENS
China Isotope & Radiation
Dongcheng Pharmaceutical Group
Lantheus
Eli Lilly
1 Diagnostic Radiopharmaceuticals Market Overview
1.1 Diagnostic Radiopharmaceuticals Product Scope
1.2 Diagnostic Radiopharmaceuticals Segment by Type
1.2.1 Global Diagnostic Radiopharmaceuticals Sales by Type (2020-2026)
1.2.2 Technetium 99
1.2.3 Fluorine 18
1.2.4 Other
1.3 Diagnostic Radiopharmaceuticals Segment by Application
1.3.1 Global Diagnostic Radiopharmaceuticals Sales Comparison by Application (2020-2026)
1.3.2 Oncology
1.3.3 Cardiology
1.3.4 Other
1.4 Diagnostic Radiopharmaceuticals Market Estimates and Forecasts (2015-2026)
1.4.1 Global Diagnostic Radiopharmaceuticals Sales Growth Rate (2015-2026)
1.4.2 Global Diagnostic Radiopharmaceuticals Revenue and Growth Rate (2015-2026)
1.4.3 Global Diagnostic Radiopharmaceuticals Price Trends (2015-2026)
2 Diagnostic Radiopharmaceuticals Estimate and Forecast by Region
2.1 Global Diagnostic Radiopharmaceuticals Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Diagnostic Radiopharmaceuticals Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Diagnostic Radiopharmaceuticals Sales Market Share by Region (2015-2020)
2.2.2 Global Diagnostic Radiopharmaceuticals Revenue Market Share by Region (2015-2020)
2.3 Global Diagnostic Radiopharmaceuticals Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Diagnostic Radiopharmaceuticals Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Diagnostic Radiopharmaceuticals Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Diagnostic Radiopharmaceuticals Estimates and Projections (2015-2026)
2.4.2 Europe Diagnostic Radiopharmaceuticals Estimates and Projections (2015-2026)
2.4.3 China Diagnostic Radiopharmaceuticals Estimates and Projections (2015-2026)
2.4.4 Japan Diagnostic Radiopharmaceuticals Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Diagnostic Radiopharmaceuticals Estimates and Projections (2015-2026)
2.4.6 India Diagnostic Radiopharmaceuticals Estimates and Projections (2015-2026)
3 Global Diagnostic Radiopharmaceuticals Competition Landscape by Players
3.1 Global Top Diagnostic Radiopharmaceuticals Players by Sales (2015-2020)
3.2 Global Top Diagnostic Radiopharmaceuticals Players by Revenue (2015-2020)
3.3 Global Diagnostic Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Diagnostic Radiopharmaceuticals as of 2019)
3.4 Global Diagnostic Radiopharmaceuticals Average Price by Company (2015-2020)
3.5 Manufacturers Diagnostic Radiopharmaceuticals Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Diagnostic Radiopharmaceuticals Players (Opinion Leaders)
4 Global Diagnostic Radiopharmaceuticals Market Size by Type
4.1 Global Diagnostic Radiopharmaceuticals Historic Market Review by Type (2015-2020)
4.1.1 Global Diagnostic Radiopharmaceuticals Sales Market Share by Type (2015-2020)
4.1.2 Global Diagnostic Radiopharmaceuticals Revenue Market Share by Type (2015-2020)
4.1.3 Global Diagnostic Radiopharmaceuticals Price by Type (2015-2020)
4.2 Global Diagnostic Radiopharmaceuticals Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Diagnostic Radiopharmaceuticals Sales Forecast by Type (2021-2026)
4.2.2 Global Diagnostic Radiopharmaceuticals Revenue Forecast by Type (2021-2026)
4.2.3 Global Diagnostic Radiopharmaceuticals Price Forecast by Type (2021-2026)
5 Global Diagnostic Radiopharmaceuticals Market Size by Application
5.1 Global Diagnostic Radiopharmaceuticals Historic Market Review by Application (2015-2020)
5.1.1 Global Diagnostic Radiopharmaceuticals Sales Market Share by Application (2015-2020)
5.1.2 Global Diagnostic Radiopharmaceuticals Revenue Market Share by Application (2015-2020)
5.1.3 Global Diagnostic Radiopharmaceuticals Price by Application (2015-2020)
5.2 Global Diagnostic Radiopharmaceuticals Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Diagnostic Radiopharmaceuticals Sales Forecast by Application (2021-2026)
5.2.2 Global Diagnostic Radiopharmaceuticals Revenue Forecast by Application (2021-2026)
5.2.3 Global Diagnostic Radiopharmaceuticals Price Forecast by Application (2021-2026)
6 United States Diagnostic Radiopharmaceuticals Market Facts & Figures
6.1 United States Diagnostic Radiopharmaceuticals Sales Market Share by Company (2015-2020)
6.2 United States Diagnostic Radiopharmaceuticals Sales Market Share by Type (2015-2020)
6.3 United States Diagnostic Radiopharmaceuticals Sales Market Share by Application (2015-2020)
7 Europe Diagnostic Radiopharmaceuticals Market Facts & Figures
7.1 Europe Diagnostic Radiopharmaceuticals Sales Market Share by Company (2015-2020)
7.2 Europe Diagnostic Radiopharmaceuticals Sales Market Share by Type (2015-2020)
7.3 Europe Diagnostic Radiopharmaceuticals Sales Market Share by Application (2015-2020)
8 China Diagnostic Radiopharmaceuticals Market Facts & Figures
8.1 China Diagnostic Radiopharmaceuticals Sales Market Share by Company (2015-2020)
8.2 China Diagnostic Radiopharmaceuticals Sales Market Share by Type (2015-2020)
8.3 China Diagnostic Radiopharmaceuticals Sales Market Share by Application (2015-2020)
9 Japan Diagnostic Radiopharmaceuticals Market Facts & Figures
9.1 Japan Diagnostic Radiopharmaceuticals Sales Market Share by Company (3015-3030)
9.2 Japan Diagnostic Radiopharmaceuticals Sales Market Share by Type (2015-2020)
9.3 Japan Diagnostic Radiopharmaceuticals Sales Market Share by Application (2015-2020)
10 Southeast Asia Diagnostic Radiopharmaceuticals Market Facts & Figures
10.1 Southeast Asia Diagnostic Radiopharmaceuticals Sales Market Share by Company (2015-2020)
10.2 Southeast Asia Diagnostic Radiopharmaceuticals Sales Market Share by Type (2015-2020)
10.3 Southeast Asia Diagnostic Radiopharmaceuticals Sales Market Share by Application (2015-2020)
11 India Diagnostic Radiopharmaceuticals Market Facts & Figures
11.1 India Diagnostic Radiopharmaceuticals Sales Market Share by Company (2015-2020)
11.2 India Diagnostic Radiopharmaceuticals Sales Market Share by Type (2015-2020)
11.3 India Diagnostic Radiopharmaceuticals Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Diagnostic Radiopharmaceuticals Business
12.1 Cardinal Health
12.1.1 Cardinal Health Corporation Information
12.1.2 Cardinal Health Business Overview
12.1.3 Cardinal Health Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Cardinal Health Diagnostic Radiopharmaceuticals Products Offered
12.1.5 Cardinal Health Recent Development
12.2 GE Healthcare
12.2.1 GE Healthcare Corporation Information
12.2.2 GE Healthcare Business Overview
12.2.3 GE Healthcare Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
12.2.4 GE Healthcare Diagnostic Radiopharmaceuticals Products Offered
12.2.5 GE Healthcare Recent Development
12.3 Curium Pharma
12.3.1 Curium Pharma Corporation Information
12.3.2 Curium Pharma Business Overview
12.3.3 Curium Pharma Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Curium Pharma Diagnostic Radiopharmaceuticals Products Offered
12.3.5 Curium Pharma Recent Development
12.4 Jubilant Pharma
12.4.1 Jubilant Pharma Corporation Information
12.4.2 Jubilant Pharma Business Overview
12.4.3 Jubilant Pharma Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Jubilant Pharma Diagnostic Radiopharmaceuticals Products Offered
12.4.5 Jubilant Pharma Recent Development
12.5 Bracco Imaging
12.5.1 Bracco Imaging Corporation Information
12.5.2 Bracco Imaging Business Overview
12.5.3 Bracco Imaging Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Bracco Imaging Diagnostic Radiopharmaceuticals Products Offered
12.5.5 Bracco Imaging Recent Development
12.6 Advanced Accelerator Applications
12.6.1 Advanced Accelerator Applications Corporation Information
12.6.2 Advanced Accelerator Applications Business Overview
12.6.3 Advanced Accelerator Applications Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Advanced Accelerator Applications Diagnostic Radiopharmaceuticals Products Offered
12.6.5 Advanced Accelerator Applications Recent Development
12.7 SIEMENS
12.7.1 SIEMENS Corporation Information
12.7.2 SIEMENS Business Overview
12.7.3 SIEMENS Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
12.7.4 SIEMENS Diagnostic Radiopharmaceuticals Products Offered
12.7.5 SIEMENS Recent Development
12.8 China Isotope & Radiation
12.8.1 China Isotope & Radiation Corporation Information
12.8.2 China Isotope & Radiation Business Overview
12.8.3 China Isotope & Radiation Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
12.8.4 China Isotope & Radiation Diagnostic Radiopharmaceuticals Products Offered
12.8.5 China Isotope & Radiation Recent Development
12.9 Dongcheng Pharmaceutical Group
12.9.1 Dongcheng Pharmaceutical Group Corporation Information
12.9.2 Dongcheng Pharmaceutical Group Business Overview
12.9.3 Dongcheng Pharmaceutical Group Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Dongcheng Pharmaceutical Group Diagnostic Radiopharmaceuticals Products Offered
12.9.5 Dongcheng Pharmaceutical Group Recent Development
12.10 Lantheus
12.10.1 Lantheus Corporation Information
12.10.2 Lantheus Business Overview
12.10.3 Lantheus Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Lantheus Diagnostic Radiopharmaceuticals Products Offered
12.10.5 Lantheus Recent Development
12.11 Eli Lilly
12.11.1 Eli Lilly Corporation Information
12.11.2 Eli Lilly Business Overview
12.11.3 Eli Lilly Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Eli Lilly Diagnostic Radiopharmaceuticals Products Offered
12.11.5 Eli Lilly Recent Development
13 Diagnostic Radiopharmaceuticals Manufacturing Cost Analysis
13.1 Diagnostic Radiopharmaceuticals Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Diagnostic Radiopharmaceuticals
13.4 Diagnostic Radiopharmaceuticals Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Diagnostic Radiopharmaceuticals Distributors List
14.3 Diagnostic Radiopharmaceuticals Customers
15 Market Dynamics
15.1 Diagnostic Radiopharmaceuticals Market Trends
15.2 Diagnostic Radiopharmaceuticals Opportunities and Drivers
15.3 Diagnostic Radiopharmaceuticals Market Challenges
15.4 Diagnostic Radiopharmaceuticals Market Restraints
15.5 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Diagnostic Radiopharmaceuticals Sales (K Units) Growth Rate by Type (2020-2026) (US$ Million)
Table 2. Global Diagnostic Radiopharmaceuticals Sales (K Units) Comparison by Application (2020-2026) (US$ Million)
Table 3. Global Market Diagnostic Radiopharmaceuticals Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Diagnostic Radiopharmaceuticals Sales (K Units) by Region (2015-2020)
Table 5. Global Diagnostic Radiopharmaceuticals Sales Market Share by Region (2015-2020)
Table 6. Global Diagnostic Radiopharmaceuticals Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Diagnostic Radiopharmaceuticals Revenue Share by Region (2015-2020)
Table 8. Global Diagnostic Radiopharmaceuticals Sales (K Units) Forecast by Region (2021-2026)
Table 9. Global Diagnostic Radiopharmaceuticals Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Diagnostic Radiopharmaceuticals Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Diagnostic Radiopharmaceuticals Revenue Share Forecast by Region (2021-2026)
Table 12. Global Diagnostic Radiopharmaceuticals (K Units) of Key Companies (2015-2020)
Table 13. Global Diagnostic Radiopharmaceuticals Sales Share by Company (2015-2020)
Table 14. Global Diagnostic Radiopharmaceuticals Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Diagnostic Radiopharmaceuticals Revenue Share by Company (2015-2020)
Table 16. Global Diagnostic Radiopharmaceuticals by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Diagnostic Radiopharmaceuticals as of 2019)
Table 17. Global Diagnostic Radiopharmaceuticals Average Price (US$/Unit) of Key Company (2015-2020)
Table 18. Manufacturers Diagnostic Radiopharmaceuticals Manufacturing Sites and Area Served
Table 19. Manufacturers Diagnostic Radiopharmaceuticals Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Diagnostic Radiopharmaceuticals Players
Table 22. Global Diagnostic Radiopharmaceuticals Sales (K Units) by Type (2015-2020)
Table 23. Global Diagnostic Radiopharmaceuticals Sales Share by Type (2015-2020)
Table 24. Global Diagnostic Radiopharmaceuticals Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Diagnostic Radiopharmaceuticals Price (K Units) by Type (2015-2020)
Table 26. Global Diagnostic Radiopharmaceuticals Sales Share by Type (2021-2026)
Table 27. Global Diagnostic Radiopharmaceuticals Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Diagnostic Radiopharmaceuticals Revenue Share by Type (2021-2026)
Table 29. Global Diagnostic Radiopharmaceuticals Price (K Units) by Type (2021-2026)
Table 30. Global Diagnostic Radiopharmaceuticals Sales (K Units) by Application (2015-2020)
Table 31. Global Diagnostic Radiopharmaceuticals Sales Share by Application (2015-2020)
Table 32. Global Diagnostic Radiopharmaceuticals Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Diagnostic Radiopharmaceuticals Price (K Units) by Application (2015-2020)
Table 34. Global Diagnostic Radiopharmaceuticals Sales (K Units) by Application (2021-2026)
Table 35. Global Diagnostic Radiopharmaceuticals Sales Share by Application (2021-2026)
Table 36. Global Diagnostic Radiopharmaceuticals Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Diagnostic Radiopharmaceuticals Revenue Share by Application (2021-2026)
Table 38. Global Diagnostic Radiopharmaceuticals Price (K Units) by Application (2021-2026)
Table 39. United States Diagnostic Radiopharmaceuticals Sales (K Units) by Company (2015-2020)
Table 40. United States Diagnostic Radiopharmaceuticals Sales Market Share by Company (2015-2020)
Table 41. United States Diagnostic Radiopharmaceuticals Sales (K Units) by Type (2015-2020)
Table 42. United States Diagnostic Radiopharmaceuticals Sales Market Share by Type (2015-2020)
Table 43. United States Diagnostic Radiopharmaceuticals Sales (K Units) by Application (2015-2020)
Table 44. United States Diagnostic Radiopharmaceuticals Sales Market Share by Application (2015-2020)
Table 45. Europe Diagnostic Radiopharmaceuticals Sales (K Units) by Company (2015-2020)
Table 46. Europe Diagnostic Radiopharmaceuticals Sales Market Share by Company (2015-2020)
Table 47. Europe Diagnostic Radiopharmaceuticals Sales (K Units) by Type (2015-2020)
Table 48. Europe Diagnostic Radiopharmaceuticals Sales Market Share by Type (2015-2020)
Table 49. Europe Diagnostic Radiopharmaceuticals Sales (K Units) by Application (2015-2020)
Table 50. Europe Diagnostic Radiopharmaceuticals Sales Market Share by Type (2015-2020)
Table 51. China Diagnostic Radiopharmaceuticals Sales (K Units) by Company (2015-2020)
Table 52. China Diagnostic Radiopharmaceuticals Sales Market Share by Company (2015-2020)
Table 53. China Diagnostic Radiopharmaceuticals Sales (K Units) by Type (2015-2020)
Table 54. China Diagnostic Radiopharmaceuticals Sales Market Share by Type (2015-2020)
Table 55. China Diagnostic Radiopharmaceuticals Sales (K Units) by Application (2015-2020)
Table 56. China Diagnostic Radiopharmaceuticals Sales Market Share by Application (2015-2020)
Table 57. Japan Diagnostic Radiopharmaceuticals Sales (K Units) by Company (2015-2020)
Table 58. Japan Diagnostic Radiopharmaceuticals Sales Market Share by Company (2015-2020)
Table 59. Japan Diagnostic Radiopharmaceuticals Sales (K Units) by Type (2015-2020)
Table 60. Japan Diagnostic Radiopharmaceuticals Sales Market Share by Type (2015-2020)
Table 61. Japan Diagnostic Radiopharmaceuticals Sales (K Units) by Application (2015-2020)
Table 62. Japan Diagnostic Radiopharmaceuticals Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Diagnostic Radiopharmaceuticals Sales (K Units) by Company (2015-2020)
Table 64. Southeast Asia Diagnostic Radiopharmaceuticals Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Diagnostic Radiopharmaceuticals Sales (K Units) by Type (2015-2020)
Table 66. Southeast Asia Diagnostic Radiopharmaceuticals Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Diagnostic Radiopharmaceuticals Sales (K Units) by Type (2015-2020)
Table 68. Southeast Asia Diagnostic Radiopharmaceuticals Sales Market Share by Application (2015-2020)
Table 69. India Diagnostic Radiopharmaceuticals Sales (K Units) by Company (2015-2020)
Table 70. India Diagnostic Radiopharmaceuticals Sales Market Share by Company (2015-2020)
Table 71. India Diagnostic Radiopharmaceuticals Sales (K Units) by Type (2015-2020)
Table 72. India Diagnostic Radiopharmaceuticals Sales Market Share by Type (2015-2020)
Table 73. India Diagnostic Radiopharmaceuticals Sales (K Units) by Application (2015-2020)
Table 74. India Diagnostic Radiopharmaceuticals Sales Market Share by Application (2015-2020)
Table 75. Cardinal Health Corporation Information
Table 76. Cardinal Health Description and Business Overview
Table 77. Cardinal Health Diagnostic Radiopharmaceuticals Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2015-2020)
Table 78. Cardinal Health Diagnostic Radiopharmaceuticals Product
Table 79. Cardinal Health Recent Development
Table 80. GE Healthcare Corporation Information
Table 81. GE Healthcare Description and Business Overview
Table 82. GE Healthcare Diagnostic Radiopharmaceuticals Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2015-2020)
Table 83. GE Healthcare Diagnostic Radiopharmaceuticals Product
Table 84. GE Healthcare Recent Development
Table 85. Curium Pharma Corporation Information
Table 86. Curium Pharma Description and Business Overview
Table 87. Curium Pharma Diagnostic Radiopharmaceuticals Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2015-2020)
Table 88. Curium Pharma Diagnostic Radiopharmaceuticals Product
Table 89. Curium Pharma Recent Development
Table 90. Jubilant Pharma Corporation Information
Table 91. Jubilant Pharma Description and Business Overview
Table 92. Jubilant Pharma Diagnostic Radiopharmaceuticals Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2015-2020)
Table 93. Jubilant Pharma Diagnostic Radiopharmaceuticals Product
Table 94. Jubilant Pharma Recent Development
Table 95. Bracco Imaging Corporation Information
Table 96. Bracco Imaging Description and Business Overview
Table 97. Bracco Imaging Diagnostic Radiopharmaceuticals Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2015-2020)
Table 98. Bracco Imaging Diagnostic Radiopharmaceuticals Product
Table 99. Bracco Imaging Recent Development
Table 100. Advanced Accelerator Applications Corporation Information
Table 101. Advanced Accelerator Applications Description and Business Overview
Table 102. Advanced Accelerator Applications Diagnostic Radiopharmaceuticals Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2015-2020)
Table 103. Advanced Accelerator Applications Diagnostic Radiopharmaceuticals Product
Table 104. Advanced Accelerator Applications Recent Development
Table 105. SIEMENS Corporation Information
Table 106. SIEMENS Description and Business Overview
Table 107. SIEMENS Diagnostic Radiopharmaceuticals Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2015-2020)
Table 108. SIEMENS Diagnostic Radiopharmaceuticals Product
Table 109. SIEMENS Recent Development
Table 110. China Isotope & Radiation Corporation Information
Table 111. China Isotope & Radiation Diagnostic Radiopharmaceuticals Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2015-2020)
Table 112. China Isotope & Radiation Description and Business Overview
Table 113. China Isotope & Radiation Diagnostic Radiopharmaceuticals Product
Table 114. China Isotope & Radiation Recent Development
Table 115. Dongcheng Pharmaceutical Group Corporation Information
Table 116. Dongcheng Pharmaceutical Group Diagnostic Radiopharmaceuticals Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2015-2020)
Table 117. Dongcheng Pharmaceutical Group Description and Business Overview
Table 118. Dongcheng Pharmaceutical Group Diagnostic Radiopharmaceuticals Product
Table 119. Dongcheng Pharmaceutical Group Recent Development
Table 120. Lantheus Corporation Information
Table 121. Lantheus Description and Business Overview
Table 122. Lantheus Diagnostic Radiopharmaceuticals Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2015-2020)
Table 123. Lantheus Diagnostic Radiopharmaceuticals Product
Table 124. Lantheus Recent Development
Table 125. Eli Lilly Corporation Information
Table 126. Eli Lilly Description and Business Overview
Table 127. Eli Lilly Diagnostic Radiopharmaceuticals Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2015-2020)
Table 128. Eli Lilly Diagnostic Radiopharmaceuticals Product
Table 129. Eli Lilly Recent Development
Table 130. Production Base and Market Concentration Rate of Raw Material
Table 131. Key Suppliers of Raw Materials
Table 132. Diagnostic Radiopharmaceuticals Distributors List
Table 133. Diagnostic Radiopharmaceuticals Customers List
Table 134. Diagnostic Radiopharmaceuticals Market Key Trends
Table 135. Diagnostic Radiopharmaceuticals Key Opportunities and Drivers
Table 136. Diagnostic Radiopharmaceuticals Market Challenges
Table 137. Research Programs/Design for This Report
Table 138. Key Data Information from Secondary Sources
Table 139. Key Data Information from Primary Sources
List of Figures
Figure 1. Diagnostic Radiopharmaceuticals Product Picture
Figure 2. Global Diagnostic Radiopharmaceuticals Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Diagnostic Radiopharmaceuticals Market Share by Application in 2020 & 2026
Figure 6. Oncology Examples
Figure 7. Cardiology Examples
Figure 8. Other Examples
Figure 9. Global Diagnostic Radiopharmaceuticals Sales (K Units) Growth Rate (2015-2026)
Figure 10. Global Diagnostic Radiopharmaceuticals Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global Diagnostic Radiopharmaceuticals Price Trends Growth Rate (2015-2026) (US$/Unit)
Figure 12. Global Diagnostic Radiopharmaceuticals Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global Diagnostic Radiopharmaceuticals Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States Diagnostic Radiopharmaceuticals Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States Diagnostic Radiopharmaceuticals Sales (K Units) Growth Rate (2015-2026)
Figure 16. Europe Diagnostic Radiopharmaceuticals Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe Diagnostic Radiopharmaceuticals Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China Diagnostic Radiopharmaceuticals Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China Diagnostic Radiopharmaceuticals Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan Diagnostic Radiopharmaceuticals Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan Diagnostic Radiopharmaceuticals Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Diagnostic Radiopharmaceuticals Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Diagnostic Radiopharmaceuticals Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India Diagnostic Radiopharmaceuticals Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India Diagnostic Radiopharmaceuticals Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest Diagnostic Radiopharmaceuticals Players Market Share by Revenue in Diagnostic Radiopharmaceuticals 2015 & 2019
Figure 27. Diagnostic Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global Diagnostic Radiopharmaceuticals Revenue Share by Type (2015-2020)
Figure 29. Global Diagnostic Radiopharmaceuticals Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global Diagnostic Radiopharmaceuticals Revenue Share by Application (2015-2020)
Figure 31. Global Diagnostic Radiopharmaceuticals Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States Diagnostic Radiopharmaceuticals Sales Market Share by Type in 2019
Figure 33. United States Diagnostic Radiopharmaceuticals Sales Market Share by Type in 2019
Figure 34. Europe Diagnostic Radiopharmaceuticals Sales Market Share by Company in 2019
Figure 35. Europe Diagnostic Radiopharmaceuticals Sales Market Share by Type in 2019
Figure 36. Europe Diagnostic Radiopharmaceuticals Sales Market Share by Application in 2019
Figure 37. China Diagnostic Radiopharmaceuticals Sales Market Share by Company in 2019
Figure 38. China Diagnostic Radiopharmaceuticals Sales Market Share by Type in 2019
Figure 39. China Diagnostic Radiopharmaceuticals Sales Market Share by Application in 2019
Figure 40. Japan Diagnostic Radiopharmaceuticals Sales Market Share by Company in 2019
Figure 41. Japan Diagnostic Radiopharmaceuticals Sales Market Share by Type in 2019
Figure 42. Japan Diagnostic Radiopharmaceuticals Sales Market Share by Application in 2019
Figure 43. Southeast Asia Diagnostic Radiopharmaceuticals Sales Market Share by Company in 2019
Figure 44. Southeast Asia Diagnostic Radiopharmaceuticals Sales Market Share by Type in 2019
Figure 45. Southeast Asia Diagnostic Radiopharmaceuticals Sales Market Share by Application in 2019
Figure 46. India Diagnostic Radiopharmaceuticals Sales Market Share by Company in 2019
Figure 47. India Diagnostic Radiopharmaceuticals Sales Market Share by Type in 2019
Figure 48. India Diagnostic Radiopharmaceuticals Sales Market Share by Application in 2019
Figure 49. Key Raw Materials Price Trend
Figure 50. Manufacturing Cost Structure of Diagnostic Radiopharmaceuticals
Figure 51. Manufacturing Process Analysis of Diagnostic Radiopharmaceuticals
Figure 52. Diagnostic Radiopharmaceuticals Industrial Chain Analysis
Figure 53. Channels of Distribution
Figure 54. Distributors Profiles
Figure 55. Porter's Five Forces Analysis
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
核医学における放射性医薬品の世界市場レポート2020 Market Analysis and Insights: Global Radiopharmaceuticals in Nuclear Medical Market The global Radiopharmaceuticals in Nuclear Medical market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Radiopharmaceuticals in Nuclear Medi…- 神経学的診断機器の世界市場レポート2020 Market Analysis and Insights: Global Neurological Diagnostic Equipment Market The global Neurological Diagnostic Equipment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Neurological Diagnostic Equipment Scope and Mark…
- 診断用ECGスキャナーの世界市場レポート2020 Market Analysis and Insights: Global Diagnostic ECG Scanner Market The global Diagnostic ECG Scanner market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Diagnostic ECG Scanner Scope and Market Size The global Diagnostic ECG…
- 診断用ティンパノメーターの世界市場レポート2020 Diagnostic tympanometer is an instrument that measures movement of the tympanic membrane at various levels of air pressure, used to assess function of the middle ear. Market Analysis and Insights: Global Diagnostic Tympanometers Market The global Diagnostic Tympanometers market size is projected to …
- 診断用聴力計の世界市場レポート2020 Audiometer is a device used to evaluate hearing loss during an audiology test. Usually, it is an individual piece of hardware that delivers pure tones of controlled intensity to one ear at a time, to which a patient responds when they can hear the tone. Many modern devices can either be used alone o…